News | January 25, 2024
Aarti Drugs posts Q3 FY24 consolidated PAT at Rs. 36.71 Cr
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
Atlas AI combines NVIDIA BioNeMo cloud APIs for intelligent chemical and protein design
Varenicline Tablets (RLD Chantix) had estimated annual sales of US $412 million in the US
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
Clariant Healthcare highlighted Vitipure Meglumine LEX and VitiPure Superior at the recently concluded CPhI India
Equipped with most advanced Distributed Control System (DCS) automation technology, the facility has been set up with an investment of Rs. 200 crore
EBITDA for Q2 FY24 at Rs. 71.2 crore as compared to Rs. 79.9 crore QoQ
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
Subscribe To Our Newsletter & Stay Updated
